Medications for Coronary Heart Disease

4 results

  • atorvaliq - atorvaliq suspension

    (Atorvaliq)
    Cmp Pharma, Inc.
    Atorvaliq reduces cardiovascular risk (MI, stroke, angina) in adults with CHD risk factors, established CHD, or type 2 diabetes. Also lowers LDL-C in adults and children 10+ with primary hyperlipidemia, familial hypercholesterolemia, dysbetalipoproteinemia, or hypertriglyceridemia.
    Medication Details
    Drug Interactions

  • norliqva - amlodipine solution

    (Amlodipine)
    Cmp Pharma, Inc.
    Norliqva is a calcium channel blocker indicated for hypertension in adults and children 6+ to lower blood pressure, and for coronary artery disease including chronic stable angina, vasospastic angina, and angiographically documented CAD to reduce hospitalization and revascularization risk.
    Medication Details
    Drug Interactions

  • praluent - alirocumab injection, solution

    (Alirocumab)
    Regeneron Pharmaceuticals, Inc.
    Praluent reduces LDL cholesterol in adults with hypercholesterolemia, HeFH, or HoFH (ages 8+), and lowers the risk of major cardiovascular events—heart attack, stroke, coronary death, or unstable angina—in high-risk adults.
    Medication Details
    Drug Interactions

  • xarelto - rivaroxaban tablet, film coated

    (Rivaroxaban)
    Janssen Pharmaceuticals, Inc.
    Xarelto is a factor Xa inhibitor that reduces stroke risk in atrial fibrillation, treats and prevents DVT and pulmonary embolism, lowers cardiovascular risk in CAD and PAD (with aspirin), and provides VTE prophylaxis after joint replacement surgery, in hospitalized medical patients, and in pediatric patients.
    Medication Details
    Drug Interactions